Recall Register

Drug recall: Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS…

Class III FDA enforcement event 98856. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Golden State Medical Supply Inc. started this drug recall on 27 Apr 2026. The firm address in the FDA record is in Camarillo, CA. FDA put the recall in Class III. FDA event 98856 has 2 product records. The first FDA enforcement report date is 27 May 2026. The record gives the status Ongoing. 50 of the 281 drug events that started in 2026 have more product records. The median drug event of 2026 has 1 product record.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

USA Nationwide

Recalling firm

Golden State Medical Supply Inc., Camarillo, CA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 98856: product records
Recall numberProductQuantityClassStatusReport date
D-0534-2026Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-637-058,526 bottlesClass IIIOngoing27 May 2026
D-0535-2026Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-638-011,620 bottlesClass IIIOngoing27 May 2026

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2026
281
Share of these events in Class III
14%
Product records in this event
2Median of the firm: 1
Events of the firm on the register
32

Other events of the firm

Other FDA enforcement events of Golden State Medical Supply Inc.
InitiatedProduct (first record)TypeClassRecords
21 Aug 2026Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, DrugClass II1
7 Aug 2026Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-DrugClass II1
29 May 2026GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban PhDrugClass II1
26 Nov 2025Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-1DrugClass II1
20 Oct 2025NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban PharmaceuDrugClass II1
5 Mar 2025PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-3DrugClass II1
13 May 2024Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30; b) 90 capsules bottleDrugClass II1
14 Feb 2024Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: ADrugClass II1
12 Jan 2024Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPDrugClass II1
10 Nov 2023PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDC 60429-734-90; cDrugClass II3

Golden State Medical Supply Inc.: all 32 events

Official channels

Cite this page

Recall Register. FDA enforcement event 98856. https://recallregister.com/fda/iii/98856/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: USA Nationwide
What quantity of product is in FDA event 98856?
The event has 2 product records. The first record gives this quantity: 8,526 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2026 have the same class?
14% of the 281 drug events that started in 2026 are in Class III.